Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2009

View Archived Issues

Threitol ceramide, an agonist of invariant NKT cells, may be used as vaccine adjuvant

New triptorelin 6-month formulation safe and efficacious in prostate cancer patients

Novel histone deacetylase inhibitors presented by ArQule

Combining PARP and DNA topoisomerase I inhibitor causes increased toxicity in cancer patients

PSA failures less common with degarelix than with leuprolide in phase III trial

Pfizer provides pipeline update in high-priority disease areas

BTG presents update on clinical development activities for year ended March 2009

Recent GSK patents describe novel Akt inhibitors for cancer treatment

Roche describes novel TAAR1 ligands and their use as antidepressants

New compounds for the treatment of diabetes reported by Boehringer Ingelheim

Potassium channel modulators in early development at Valeant for the treatment of epilepsy

Novel beta-secretase inhibitor shows activity in mouse model of Alzheimer's disease

FDA Advisory Committee discusses liraglutide for the treatment of type 2 diabetes

Pharmos provides update on phase II dextofisopam trial

Traversa Therapeutics' Series B financing to fund RNAi oncology programs

NIH grant to fund study of Cerashield coating in orthopedic implants

OXI-4503 begins phase Ib/IIa study in solid tumors with hepatic involvement

PPD expands its compound partnering program into dermatology

NDA for Zegerid tablet accepted for filing

KS-C370G shows cardioprotective activity in rat model of type 1 diabetes

Japanese launch for Recalbon/Bonoteo Tablets

Patient achieves insulin independence with Diabecell in phase I/IIa trial

AstraZeneca receives FDA complete response on Symbicort for pediatric asthma

Capstone initiates dosing in phase II AZX-100 pilot study in keloid scarring

Eisai enters into agreement with Nobelpharma for Gliadel Wafer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...